About the Authors
- Nicolas Deblon
-
Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Christelle Veyrat-Durebex
-
Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Lucie Bourgoin
-
Affiliation Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Aurélie Caillon
-
Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Anne-Lise Bussier
-
Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Stefania Petrosino
-
Affiliation Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Naples, Italy
- Fabiana Piscitelli
-
Affiliation Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Naples, Italy
- Jean-Jacques Legros
-
Affiliation Centre Hospitalier Régional de la Citadelle, University of Liege, Liege, Belgium
- Vincent Geenen
-
Affiliation Centre of Immunology, University of Liege, CHU B-23, Liege, Belgium
- Michelangelo Foti
-
Affiliation Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Walter Wahli
-
Affiliation Center for Integrative Genomics, National Research Center Frontiers in Genetics, University of Lausanne, Lausanne, Switzerland
- Vincenzo Di Marzo
-
Affiliation Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Naples, Italy
- Françoise Rohner-Jeanrenaud
-
* E-mail: francoise.jeanrenaud@unige.ch
Affiliation Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Competing Interests
The authors have read the journal's policy and have the following conflicts: Patent application N° PCT/IB2011/052156 covering novel therapeutic uses of oxytocin has been filed on 17 May 2011. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ND FRJ. Performed the experiments: ND FRJ CVD LB MF AC ALB SP VDM FP. Analyzed the data: ND. Contributed reagents/materials/analysis tools: JJL WW VG. Wrote the paper: ND FRJ.